Search
Browse
Statistics
Feeds

Browse by Journal Title

Group by: Date | Item Type
Jump to: 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016

2026

Non-temperature-induced antitumor effects of amplitude-modulated radiofrequency: molecular and functional synergies with radiotherapy.
Veltsista, Paraskevi D., Walther, Wolfgang ORCID logoORCID: https://orcid.org/0000-0003-2360-1370, Torke, Sebastian ORCID logoORCID: https://orcid.org/0000-0002-1029-3623, Ivanov, Andranik ORCID logoORCID: https://orcid.org/0000-0002-4824-1925, Dieper, Anna, Beule, Dieter ORCID logoORCID: https://orcid.org/0000-0002-3284-0632, Zips, Daniel, Stein, Ulrike ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Ghadjar, Pirus
Cancers 18 (10): 1613. May 2026

Biological advances and current challenges for pediatric rhabdomyosarcoma.
Hebron, Katie E. ORCID logoORCID: https://orcid.org/0000-0002-4740-8930, Odeniyide, Patience ORCID logoORCID: https://orcid.org/0000-0002-9783-1657, Wei, Yun ORCID logoORCID: https://orcid.org/0000-0003-2080-499X, Gryder, Berkley E. ORCID logoORCID: https://orcid.org/0000-0003-0130-2302, Barr, Frederic G., Casey, Dana L., Chen, Eleanor Y. ORCID logoORCID: https://orcid.org/0000-0003-4372-7560, Crompton, Brian D., Dela Cruz, Filemon S. ORCID logoORCID: https://orcid.org/0000-0002-8356-5191, Durbin, Adam D. ORCID logoORCID: https://orcid.org/0000-0002-5472-9847, Ford, Heide L., Gatz, Susanne A. ORCID logoORCID: https://orcid.org/0000-0002-6438-9778, Hatley, Mark E. ORCID logoORCID: https://orcid.org/0000-0001-7147-3946, Henssen, Anton G. ORCID logoORCID: https://orcid.org/0000-0003-1534-778X, Hettmer, Simone ORCID logoORCID: https://orcid.org/0000-0003-1709-4448, Houghton, Peter J., Kendall, Genevieve C. ORCID logoORCID: https://orcid.org/0000-0003-3775-2006, Khan, Javed ORCID logoORCID: https://orcid.org/0000-0002-5858-0488, Lupo, Philip J. ORCID logoORCID: https://orcid.org/0000-0003-0978-5863, Patel, Anand G. ORCID logoORCID: https://orcid.org/0000-0002-1438-8275, Pomella, Silvia ORCID logoORCID: https://orcid.org/0000-0002-7007-4238, Rota, Rossella ORCID logoORCID: https://orcid.org/0000-0002-9408-7711, Schito, Marco, Schoot, Reineke A., Shern, Jack F. ORCID logoORCID: https://orcid.org/0000-0001-5579-7625, Stanton, Benjamin Z. ORCID logoORCID: https://orcid.org/0000-0002-2613-2955, Stewart, Elizabeth A., Swindlehurst, Cathy A., Thomas, Craig J., Vakoc, Christopher R., Vaseva, Angelina V., Venkatramani, Rajkumar, Wexler, Leonard H., Yustein, Jason T., Hammond, Sharon, Heske, Christine M. ORCID logoORCID: https://orcid.org/0000-0003-0956-6249, Langenau, David M., Linardic, Corinne M. ORCID logoORCID: https://orcid.org/0000-0002-3257-2885, Ignatius, Myron S. and Yohe, Marielle E.
Cancers 18 (6): 888. March 2026

YAP1 enhances mesenchymal-type gene expression in human adrenergic-type neuroblastoma cells.
Ludwig, Marius ORCID logoORCID: https://orcid.org/0000-0002-7000-6040, Ahrens, Kerstin, Winkler, Annika ORCID logoORCID: https://orcid.org/0009-0007-9434-3862, Wünschel, Jasmin ORCID logoORCID: https://orcid.org/0009-0007-5658-7532, Ruka, Peris, Lodrini, Marco ORCID logoORCID: https://orcid.org/0000-0003-4434-529X, Hertwig, Falk ORCID logoORCID: https://orcid.org/0000-0003-4784-6516, Castelli, Sveva ORCID logoORCID: https://orcid.org/0000-0001-7660-5354, Thole-Kliesch, Theresa M. ORCID logoORCID: https://orcid.org/0000-0003-2714-6221, Hollander, Jan F. ORCID logoORCID: https://orcid.org/0009-0001-2907-2206, Fuchs, Steffen ORCID logoORCID: https://orcid.org/0000-0001-9619-4329, Künkele, Annette ORCID logoORCID: https://orcid.org/0000-0002-8406-5412, Jens, Marvin ORCID logoORCID: https://orcid.org/0000-0002-6660-8743, Mamlouk, Soulafa ORCID logoORCID: https://orcid.org/0000-0001-7285-1320, Warmann, Steven W. ORCID logoORCID: https://orcid.org/0009-0001-2282-2780, Astrahantseff, Kathy ORCID logoORCID: https://orcid.org/0000-0002-7872-1997, Eggert, Angelika, Schulte, Johannes H. ORCID logoORCID: https://orcid.org/0000-0003-0671-1201, Szymansky, Annabell ORCID logoORCID: https://orcid.org/0000-0003-4797-4526 and Deubzer, Hedwig E. ORCID logoORCID: https://orcid.org/0000-0002-6115-4893
Cancers 18 (3): 383. February 2026

2025

Innovative in vivo imaging and single cell expression from tumor bulk and corpus callosum reveal glioma stem cells with unique regulatory programs.
Dos Santos, Natalia, Aquino, Aline, Preußer, Friedrich ORCID logoORCID: https://orcid.org/0000-0001-8231-2195, Rusak, Fabio Rojas ORCID logoORCID: https://orcid.org/0000-0002-0637-9467, Jandrey, Elisa Helena Farias, Uno, Miyuki ORCID logoORCID: https://orcid.org/0000-0003-2589-6432, Furuya, Tatiane Katsue, Lancellotti, Carmen Lucia Penteado, Maldaun, Marcos Vinicius Calfat, Chammas, Roger ORCID logoORCID: https://orcid.org/0000-0003-0342-8726, Preibisch, Stephan ORCID logoORCID: https://orcid.org/0000-0002-0276-494X, Camargo, Anamaria Aranha, Masotti, Cibele ORCID logoORCID: https://orcid.org/0000-0003-4462-0941 and Costa, Erico Tosoni ORCID logoORCID: https://orcid.org/0000-0001-7413-4675
Cancers 17 (23): 3851. December 2025

Comparing the prognostic value of quantitative response assessment tools and LIRADS treatment response algorithm in patients with hepatocellular carcinoma following interstitial high-dose-rate brachytherapy and conventional transarterial chemoembolization.
Schmidt, R. ORCID logoORCID: https://orcid.org/0000-0003-0012-2799, Rueger, C., Xu, H., He, Y., Yilmaz, E.Y. ORCID logoORCID: https://orcid.org/0009-0004-1789-6488, Heidemann, L., Sulejmani, O. ORCID logoORCID: https://orcid.org/0000-0003-1600-317X, Liu, Y., Noack, L., Hesse, F., Ruppel, R., Abosabie, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9536-5269, Hamm, C.A., Penzkofer, T. ORCID logoORCID: https://orcid.org/0000-0001-9591-8575, Gebauer, B. ORCID logoORCID: https://orcid.org/0000-0002-9948-7220 and Savic, L.J. ORCID logoORCID: https://orcid.org/0000-0003-2115-6728
Cancers 17 (8): 1275. 9 April 2025

2024

Expression of mGluR5 in pediatric Hodgkin and Non-Hodgkin lymphoma-a comparative analysis of immunohistochemical and clinical findings regarding the association between tumor and paraneoplastic neurological disease.
Viezens, I., Knierim, E., Deubzer, H.E. ORCID logoORCID: https://orcid.org/0000-0002-6115-4893, Hauptmann, K., Fassbender, J., Morales-Gonzalez, S. ORCID logoORCID: https://orcid.org/0000-0001-7279-2092, Kaindl, A.M. ORCID logoORCID: https://orcid.org/0000-0001-9454-206X, Schuelke, M. ORCID logoORCID: https://orcid.org/0000-0003-2824-3891 and Nikolaus, M. ORCID logoORCID: https://orcid.org/0000-0002-3678-5159
Cancers 16 (13): 2452. 4 July 2024

L-glyceraldehyde inhibits neuroblastoma cell growth via a multi-modal mechanism on metabolism and Signaling.
Forbes, M. ORCID logoORCID: https://orcid.org/0000-0001-7775-8352, Kempa, R., Mastrobuoni, G. ORCID logoORCID: https://orcid.org/0000-0003-4509-1295, Rayman, L., Pietzke, M. ORCID logoORCID: https://orcid.org/0000-0002-6901-8511, Bayram, S. ORCID logoORCID: https://orcid.org/0009-0009-5245-5473, Arlt, B. ORCID logoORCID: https://orcid.org/0000-0002-6665-4037, Spruessel, A., Deubzer, H.E. ORCID logoORCID: https://orcid.org/0000-0002-6115-4893 and Kempa, S. ORCID logoORCID: https://orcid.org/0000-0002-0696-9299
Cancers 16 (9): 1664. May 2024

Immune response and metastasis-links between the metastasis driver MACC1 and cancer immune escape strategies.
Torke, S. ORCID logoORCID: https://orcid.org/0000-0002-1029-3623, Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2360-1370 and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 16 (7): 1330. 28 March 2024

MACC1 regulates LGR5 to promote cancer stem cell properties in colorectal cancer.
Erdem, M. ORCID logoORCID: https://orcid.org/0009-0009-1743-0924, Lee, K.H., Hardt, M., Regan, J.L. ORCID logoORCID: https://orcid.org/0000-0001-9987-7942, Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231, Mokrizkij, M., Regenbrecht, C. ORCID logoORCID: https://orcid.org/0000-0001-9494-5977 and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 16 (3): 604. 31 January 2024

2023

Establishment and thorough characterization of xenograft (PDX) models derived from patients with pancreatic cancer for molecular analyses and chemosensitivity testing.
Behrens, D., Pfohl, U. ORCID logoORCID: https://orcid.org/0000-0001-7203-2712, Conrad, T., Becker, M., Brzezicha, B., Büttner, B., Wagner, S. ORCID logoORCID: https://orcid.org/0009-0002-5756-8046, Hallas, C., Lawlor, R., Khazak, V., Linnebacher, M. ORCID logoORCID: https://orcid.org/0000-0001-8054-1402, Wartmann, T., Fichtner, I., Hoffmann, J., Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283 and Walther, W.
Cancers 15 (24): 5753. 8 December 2023

Mechanisms of resistance to small molecules in acute myeloid leukemia.
Lang, T.J.L., Damm, F. ORCID logoORCID: https://orcid.org/0000-0001-5553-1173, Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510 and Frick, M. ORCID logoORCID: https://orcid.org/0000-0001-5216-0565
Cancers 15 (18): 4573. 15 September 2023

Metastasis associated in colorectal cancer 1 (MACC1) mRNA expression is enhanced in sporadic vestibular schwannoma and correlates to deafness.
Breun, M., Flock, K., Feldheim, J. ORCID logoORCID: https://orcid.org/0000-0002-7297-4854, Nattmann, A., Monoranu, C.M., Herrmann, P., Ernestus, R.I., Löhr, M., Hagemann, C. ORCID logoORCID: https://orcid.org/0000-0001-9759-8149 and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 15 (16): 4089. 14 August 2023

Advanced radio frequency applicators for thermal magnetic resonance theranostics of brain tumors.
Saha, N. ORCID logoORCID: https://orcid.org/0000-0001-8555-2477, Kuehne, A. ORCID logoORCID: https://orcid.org/0000-0002-4133-5056, Millward, J.M. ORCID logoORCID: https://orcid.org/0000-0003-4484-2798, Eigentler, T.W. ORCID logoORCID: https://orcid.org/0000-0001-8252-450X, Starke, L. ORCID logoORCID: https://orcid.org/0000-0002-0359-0101, Waiczies, S. ORCID logoORCID: https://orcid.org/0000-0002-9916-9572 and Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527
Cancers 15 (8): 2303. 14 April 2023

2022

Multi-omics alleviates the limitations of panel sequencing for cancer drug response prediction.
Baranovskii, A. ORCID logoORCID: https://orcid.org/0000-0001-7217-3881, Gündüz, I.B. ORCID logoORCID: https://orcid.org/0000-0003-2641-0916, Franke, V. ORCID logoORCID: https://orcid.org/0000-0003-3606-6792, Uyar, B. ORCID logoORCID: https://orcid.org/0000-0002-3170-4890 and Akalin, A. ORCID logoORCID: https://orcid.org/0000-0002-0468-0117
Cancers 14 (22): 5604. 15 November 2022

Pre-diagnostic circulating resistin concentrations are not associated with colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study.
Pham, T.T. ORCID logoORCID: https://orcid.org/0000-0002-2129-0911, Nimptsch, K. ORCID logoORCID: https://orcid.org/0000-0001-7877-205X, Aleksandrova, K., Jenab, M. ORCID logoORCID: https://orcid.org/0000-0002-0573-1852, Reichmann, R., Wu, K., Tjønneland, A. ORCID logoORCID: https://orcid.org/0000-0003-4385-2097, Kyrø, C. ORCID logoORCID: https://orcid.org/0000-0002-9083-8960, Schulze, M.B. ORCID logoORCID: https://orcid.org/0000-0002-0830-5277, Kaaks, R., Katzke, V., Palli, D. ORCID logoORCID: https://orcid.org/0000-0002-5558-2437, Pasanisi, F. ORCID logoORCID: https://orcid.org/0000-0003-4224-7821, Ricceri, F. ORCID logoORCID: https://orcid.org/0000-0001-8749-9737, Tumino, R., Krogh, V. ORCID logoORCID: https://orcid.org/0000-0003-0122-8624, Roodhart, J., Castilla, J. ORCID logoORCID: https://orcid.org/0000-0002-6396-7265, Sánchez, M.J. ORCID logoORCID: https://orcid.org/0000-0003-4817-0757, Colorado-Yohar, S.M. ORCID logoORCID: https://orcid.org/0000-0002-6700-0780, Harbs, J., Rutegård, M. ORCID logoORCID: https://orcid.org/0000-0002-0974-6373, Papier, K. ORCID logoORCID: https://orcid.org/0000-0002-4102-6835, Aglago, E.K. ORCID logoORCID: https://orcid.org/0000-0002-0442-3284, Dimou, N., Mayen-Chacon, A.L., Weiderpass, E. ORCID logoORCID: https://orcid.org/0000-0003-2237-0128 and Pischon, T. ORCID logoORCID: https://orcid.org/0000-0003-1568-767X
Cancers 14 (22): 5499. 9 November 2022

The monocyte, a maestro in the tumor microenvironment (TME) of breast cancer.
Amer, H.T., Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and El Tayebi, H.M. ORCID logoORCID: https://orcid.org/0000-0002-6896-6018
Cancers 14 (21): 5460. 7 November 2022

Radiofrequency electromagnetic fields cause non-temperature-induced physical and biological effects in cancer cells.
Wust, P., Veltsista, P.D., Oberacker, E. ORCID logoORCID: https://orcid.org/0000-0001-7678-6677, Yavvari, P., Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231, Bengtsson, O., Sterner-Kock, A., Weinhart, M., Heyd, F., Grabowski, P., Stintzing, S. ORCID logoORCID: https://orcid.org/0000-0002-3297-5801, Heinrich, W. ORCID logoORCID: https://orcid.org/0000-0001-6113-7375, Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Ghadjar, P.
Cancers 14 (21): 5349. 30 October 2022

Concomitant cytotoxic effector differentiation of CD4(+) and CD8(+) T cells in response to EBV-Infected B cells.
Tamura, Y., Yamane, K., Kawano, Y., Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510, Wirtz, T. ORCID logoORCID: https://orcid.org/0009-0005-5677-9804, Weber, T. ORCID logoORCID: https://orcid.org/0000-0003-2079-842X, Sander, S. ORCID logoORCID: https://orcid.org/0000-0003-4645-3366, Ohki, S., Kitajima, Y. ORCID logoORCID: https://orcid.org/0000-0001-6277-5918, Okada, S. ORCID logoORCID: https://orcid.org/0000-0002-4622-5657, Rajewsky, K. ORCID logoORCID: https://orcid.org/0000-0002-6633-6370 and Yasuda, T. ORCID logoORCID: https://orcid.org/0000-0001-9997-6852
Cancers 14 (17): 4118. 25 August 2022

Core-clock genes regulate proliferation and invasion via a reciprocal interplay with MACC1 in colorectal cancer cells.
Basti, A. ORCID logoORCID: https://orcid.org/0000-0002-0153-2784, Malhan, D., Dumbani, M., Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283, Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Relógio, A. ORCID logoORCID: https://orcid.org/0000-0002-9165-2439
Cancers 14 (14): 3458. 16 July 2022

Uncovering the contribution of moderate-penetrance susceptibility genes to breast cancer by whole-exome sequencing and targeted enrichment sequencing of candidate genes in women of European ancestry.
Dumont, M. ORCID logoORCID: https://orcid.org/0000-0002-5488-4839, Weber-Lassalle, N., Joly-Beauparlant, C., Ernst, C. ORCID logoORCID: https://orcid.org/0000-0001-7756-8815, Droit, A., Feng, B.J., Dubois, S., Collin-Deschesnes, A.C., Soucy, P., Vallée, M., Fournier, F., Lemaçon, A. ORCID logoORCID: https://orcid.org/0000-0002-1817-7029, Adank, M.A., Allen, J. ORCID logoORCID: https://orcid.org/0000-0002-8677-2225, Altmüller, J. ORCID logoORCID: https://orcid.org/0000-0003-4372-1521, Arnold, N., Ausems, M.G.E.M. ORCID logoORCID: https://orcid.org/0000-0003-0305-3477, Berutti, R., Bolla, M.K., Bull, S. ORCID logoORCID: https://orcid.org/0000-0002-3280-7154, Carvalho, S., Cornelissen, S., Dufault, M.R., Dunning, A.M., Engel, C. ORCID logoORCID: https://orcid.org/0000-0002-7247-282X, Gehrig, A., Geurts-Giele, W.R.R., Gieger, C., Green, J. ORCID logoORCID: https://orcid.org/0000-0002-7005-2928, Hackmann, K., Helmy, M., Hentschel, J., Hogervorst, F.B.L., Hollestelle, A. ORCID logoORCID: https://orcid.org/0000-0003-1166-1966, Hooning, M.J., Horváth, J., Ikram, M.A., Kaulfuß, S. ORCID logoORCID: https://orcid.org/0000-0003-2577-9711, Keeman, R., Kuang, D. ORCID logoORCID: https://orcid.org/0000-0003-3554-0464, Luccarini, C., Maier, W., Martens, J.W.M. ORCID logoORCID: https://orcid.org/0000-0002-3428-3366, Niederacher, D., Nürnberg, P. ORCID logoORCID: https://orcid.org/0000-0002-7228-428X, Ott, C.E. ORCID logoORCID: https://orcid.org/0000-0003-3627-3791, Peters, A. ORCID logoORCID: https://orcid.org/0000-0001-6645-0985, Pharoah, P.D.P., Ramirez, A. ORCID logoORCID: https://orcid.org/0000-0003-4991-763X, Ramser, J., Riedel-Heller, S., Schmidt, G., Shah, M., Scherer, M., Stäbler, A., Strom, T.M., Sutter, C., Thiele, H., van Asperen, C.J., van der Kolk, L., van der Luijt, R.B., Volk, A.E., Wagner, M. ORCID logoORCID: https://orcid.org/0000-0003-2589-6440, Waisfisz, Q., Wang, Q., Wang-Gohrke, S., Weber, B.H.F. ORCID logoORCID: https://orcid.org/0000-0002-8808-7723, Devilee, P. ORCID logoORCID: https://orcid.org/0000-0002-8023-2009, Tavtigian, S., Bader, G.D. ORCID logoORCID: https://orcid.org/0000-0003-0185-8861, Meindl, A., Goldgar, D.E., Andrulis, I.L. ORCID logoORCID: https://orcid.org/0000-0002-4226-6435, Schmutzler, R.K., Easton, D.F., Schmidt, M.K. ORCID logoORCID: https://orcid.org/0000-0002-2228-429X, Hahnen, E. and Simard, J. ORCID logoORCID: https://orcid.org/0000-0001-6906-3390
Cancers 14 (14): 3363. 11 July 2022

Prevalence of cancer predisposition germline variants in male breast cancer patients: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Rolfes, M., Borde, J., Möllenhoff, K. ORCID logoORCID: https://orcid.org/0000-0001-7861-3892, Kayali, M., Ernst, C. ORCID logoORCID: https://orcid.org/0000-0001-7756-8815, Gehrig, A., Sutter, C. ORCID logoORCID: https://orcid.org/0000-0003-4051-5888, Ramser, J., Niederacher, D., Horváth, J., Arnold, N., Meindl, A., Auber, B., Rump, A., Wang-Gohrke, S., Ritter, J., Hentschel, J., Thiele, H., Altmüller, J. ORCID logoORCID: https://orcid.org/0000-0003-4372-1521, Nürnberg, P. ORCID logoORCID: https://orcid.org/0000-0002-7228-428X, Rhiem, K., Engel, C., Wappenschmidt, B., Schmutzler, R.K., Hahnen, E. and Hauke, J.
Cancers 14 (13): 3292. 5 July 2022

A RAS-independent biomarker panel to reliably predict response to MEK inhibition in colorectal cancer.
Pfohl, U., Loskutov, J., Bashir, S. ORCID logoORCID: https://orcid.org/0000-0002-1281-8710, Kühn, R. ORCID logoORCID: https://orcid.org/0000-0003-1694-9803, Herter, P. ORCID logoORCID: https://orcid.org/0000-0002-2340-2171, Templin, M., Mamlouk, S. ORCID logoORCID: https://orcid.org/0000-0001-7285-1320, Belanov, S. ORCID logoORCID: https://orcid.org/0000-0003-3419-3659, Linnebacher, M. ORCID logoORCID: https://orcid.org/0000-0001-8054-1402, Bürtin, F., Vetter, M., Reinhard, C., Wedeken, L. ORCID logoORCID: https://orcid.org/0000-0003-1061-9459 and Regenbrecht, C.R.A. ORCID logoORCID: https://orcid.org/0000-0001-9494-5977
Cancers 14 (13): 3252. 1 July 2022

Targeting Wnt/β-catenin signaling by TET1/FOXO4 inhibits metastatic spreading and self-renewal of cancer stem cells in gastric cancer.
Qi, J., Cui, D., Wu, Q.N., Zhao, Q. ORCID logoORCID: https://orcid.org/0000-0002-8683-6145, Chen, Z.H., Li, L., Birchmeier, W. ORCID logoORCID: https://orcid.org/0000-0003-1173-0829, Yu, Y. and Tao, R.
Cancers 14 (13): 3232. 30 June 2022

Evidence for recombinant GRP78, CALR, PDIA3 and GPI as mediators of genetic instability in human CD34+ cells.
Fabarius, A. ORCID logoORCID: https://orcid.org/0000-0001-5976-2876, Samra, V., Drews, O., Mörz, H., Bierbaum, M., Darwich, A. ORCID logoORCID: https://orcid.org/0000-0001-9463-9638, Weiss, C., Brendel, S., Kleiner, H., Seifarth, W., Greffrath, W., Hofmann, W.K., Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226 and Popp, H.D. ORCID logoORCID: https://orcid.org/0000-0003-0090-0204
Cancers 14 (12): 2883. 11 June 2022

MACC1-induced collective migration is promoted by proliferation rather than single cell biomechanics.
Hohmann, T. ORCID logoORCID: https://orcid.org/0000-0002-0304-7221, Hohmann, U. ORCID logoORCID: https://orcid.org/0000-0001-8376-4767, Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283, Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Dehghani, F. ORCID logoORCID: https://orcid.org/0000-0002-7615-8854
Cancers 14 (12): 2857. 9 June 2022

RB1-negative retinal organoids display proliferation of cone photoreceptors and loss of retinal differentiation.
Kanber, D., Woestefeld, J., Döpper, H., Bozet, M., Brenzel, A. ORCID logoORCID: https://orcid.org/0000-0002-6797-5457, Altmüller, J. ORCID logoORCID: https://orcid.org/0000-0003-4372-1521, Kilpert, F., Lohmann, D. ORCID logoORCID: https://orcid.org/0000-0002-2624-9889, Pommerenke, C. ORCID logoORCID: https://orcid.org/0000-0002-9448-416X and Steenpass, L. ORCID logoORCID: https://orcid.org/0000-0003-4780-0139
Cancers 14 (9): 2166. 26 April 2022

Circulating cell-free DNA assessment in biofluids from children with neuroblastoma demonstrates feasibility and potential for minimally invasive molecular diagnostics.
Lodrini, M., Wünschel, J., Thole-Kliesch, T.M., Grimaldi, M., Sprüssel, A., Linke, R.B., Hollander, J.F., Tiburtius, D., Künkele, A. ORCID logoORCID: https://orcid.org/0000-0002-8406-5412, Schulte, J.H. ORCID logoORCID: https://orcid.org/0000-0003-0671-1201, Lankes, E., Elgeti, T. ORCID logoORCID: https://orcid.org/0000-0002-7155-6044, Hundsdörfer, P., Astrahantseff, K., Simon, T., Eggert, A. ORCID logoORCID: https://orcid.org/0000-0003-3476-8184 and Deubzer, H.E. ORCID logoORCID: https://orcid.org/0000-0002-6115-4893
Cancers 14 (9): 2080. 21 April 2022

Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires.
Grunert, C. ORCID logoORCID: https://orcid.org/0000-0001-8376-8629, Willimsky, G. ORCID logoORCID: https://orcid.org/0000-0002-9693-948X, Peuker, C.A. ORCID logoORCID: https://orcid.org/0000-0002-0957-2166, Rhein, S. ORCID logoORCID: https://orcid.org/0000-0002-9445-2352, Hansmann, L. ORCID logoORCID: https://orcid.org/0000-0003-3790-0128, Blankenstein, T. ORCID logoORCID: https://orcid.org/0000-0002-3357-4321, Blanc, E. ORCID logoORCID: https://orcid.org/0000-0002-4369-0254, Beule, D. ORCID logoORCID: https://orcid.org/0000-0002-3284-0632, Keller, U. ORCID logoORCID: https://orcid.org/0000-0002-8485-1958, Pezzutto, A. ORCID logoORCID: https://orcid.org/0000-0002-3246-4470 and Busse, A. ORCID logoORCID: https://orcid.org/0000-0002-3470-6947
Cancers 14 (7): 1842. 6 April 2022

Elevated MACC1 expression in colorectal cancer is driven by chromosomal instability and is associated with molecular subtype and worse patient survival.
Vuaroqueaux, V. ORCID logoORCID: https://orcid.org/0000-0001-9120-5332, Musch, A., Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Risch, T:, Herrmann, P., Burock, S., Peille, A.L. ORCID logoORCID: https://orcid.org/0000-0003-0776-6837, Yaspo, M.L., Fiebig, H.H. and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 14 (7): 1749. 1 April 2022

Inhibition of MACC1-induced metastasis in esophageal and gastric adenocarcinomas.
Treese, C. ORCID logoORCID: https://orcid.org/0000-0001-9120-6773, Werchan, J., von Winterfeld, M., Berg, E., Hummel, M., Timm, L., Rau, B. ORCID logoORCID: https://orcid.org/0000-0001-5820-6907, Daberkow, O., Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231, Daum, S. ORCID logoORCID: https://orcid.org/0000-0003-0060-6013, Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648 and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 14 (7): 1773. 31 March 2022

Refining AML treatment: the role of genetics in response and resistance evaluation to new agents.
Halik, A., Arends, C.M. ORCID logoORCID: https://orcid.org/0000-0003-4417-4750, Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510, Damm, F. and Frick, M.
Cancers 14 (7): 1689. 26 March 2022

DLBCL 1L-what to expect beyond R-CHOP?
Stegemann, M., Denker, S. ORCID logoORCID: https://orcid.org/0000-0002-0736-6019 and Schmitt, C.A. ORCID logoORCID: https://orcid.org/0000-0002-4731-2226
Cancers 14 (6): 1453. 11 March 2022

Combination of Wnt/β-catenin targets S100A4 and DKK1 improves prognosis of human colorectal cancer.
Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283, Monks, A., Harris, E.D., Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Osterland, M. ORCID logoORCID: https://orcid.org/0000-0001-9133-9322, Khaireddine, F., Herrmann, P., Kemmner, W. ORCID logoORCID: https://orcid.org/0000-0002-1494-7225, Burock, S., Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231, Shoemaker, R.H. and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 14 (1): 37. 2022

2021

Inhibiting lysine demethylase 1A improves L1CAM-specific CAR T cell therapy by unleashing antigen-independent killing via the FAS-FASL axis.
Sulejmani, O. ORCID logoORCID: https://orcid.org/0000-0003-1600-317X, Grunewald, L., Andersch, L., Schwiebert, S., Klaus, A., Winkler, A., Astrahantseff, K., Eggert, A. ORCID logoORCID: https://orcid.org/0000-0003-3476-8184, Henssen, A.G. ORCID logoORCID: https://orcid.org/0000-0003-1534-778X, Schulte, J.H. ORCID logoORCID: https://orcid.org/0000-0003-0671-1201, Anders, K. ORCID logoORCID: https://orcid.org/0000-0002-0429-200X and Künkele, A. ORCID logoORCID: https://orcid.org/0000-0002-8406-5412
Cancers 13 (21): 5489. 31 October 2021

Current applications and future development of magnetic resonance fingerprinting in diagnosis, characterization, and response monitoring in cancer.
Ding, H. ORCID logoORCID: https://orcid.org/0000-0002-9812-2385, Velasco, C., Ye, H. ORCID logoORCID: https://orcid.org/0000-0002-7563-0352, Lindner, T. ORCID logoORCID: https://orcid.org/0000-0002-4408-2429, Grech-Sollars, M. ORCID logoORCID: https://orcid.org/0000-0003-3881-4870, O’Callaghan, J., Hiley, C., Chouhan, M.D. ORCID logoORCID: https://orcid.org/0000-0001-5903-1002, Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527, Koh, D.M., Prieto, C. and Adeleke, S. ORCID logoORCID: https://orcid.org/0000-0002-4388-8754
Cancers 13 (19): 4742. 1 October 2021

Aberrant expression of and cell death induction by engagement of the MHC-II chaperone CD74 in anaplastic large cell lymphoma (ALCL).
Wurster, K.D., Costanza, M. ORCID logoORCID: https://orcid.org/0000-0002-8959-1083, Kreher, S., Glaser, S., Lamprecht, B., Schleussner, N. ORCID logoORCID: https://orcid.org/0009-0001-3549-5600, Anagnostopoulos, I., Hummel, M., Jöhrens, K., Stein, H., Molina, A., Diepstra, A. ORCID logoORCID: https://orcid.org/0000-0001-9239-1050, Gillissen, B., Köchert, K. ORCID logoORCID: https://orcid.org/0000-0002-5548-2022, Siebert, R., Merkel, O., Kenner, L. ORCID logoORCID: https://orcid.org/0000-0003-2184-1338, Janz, M. ORCID logoORCID: https://orcid.org/0000-0002-1127-0044 and Mathas, S. ORCID logoORCID: https://orcid.org/0000-0001-9626-1413
Cancers 13 (19): 5012. 1 October 2021

Elevated Flt3L predicts long-term survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
Detjen, K.M., Otto, R. ORCID logoORCID: https://orcid.org/0000-0003-3644-743X, Giesecke, Y., Geisler, L., Riemer, P., Jann, H., Grötzinger, C. ORCID logoORCID: https://orcid.org/0000-0001-9872-3087, Sers, C., Pascher, A., Lüdde, T., Leser, U., Wiedenmann, B., Sigal, M. ORCID logoORCID: https://orcid.org/0000-0003-4772-0761, Tacke, F. ORCID logoORCID: https://orcid.org/0000-0001-6206-0226, Roderburg, C. and Hammerich, L. ORCID logoORCID: https://orcid.org/0000-0003-0557-3927
Cancers 13 (17): 4463. 1 September 2021

Effective oncoleaking treatment of pancreatic cancer by claudin-targeted suicide gene therapy with Clostridium perfringens enterotoxin (CPE).
Pahle, J., Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Aumann, J., Behrens, D., Daberkow, O., Mokritzkij, M., Piontek, J. ORCID logoORCID: https://orcid.org/0000-0002-0880-8915, Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231
Cancers 13 (17): 4393. 1 September 2021

Spontaneous non-sustained ventricular tachycardia and premature ventricular contractions and their prognostic relevance in patients with cancer in routine care.
Albrecht, A., Porthun, J. ORCID logoORCID: https://orcid.org/0000-0002-4100-4361, Eucker, J., Coats, A.J.S., von Haehling, S., Pezzutto, A. ORCID logoORCID: https://orcid.org/0000-0002-3246-4470, Karakas, M. ORCID logoORCID: https://orcid.org/0000-0002-5715-2959, Riess, H., Keller, U. ORCID logoORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., Haverkamp, W., Anker, S.D. and Anker, M.S.
Cancers 13 (10): 2303. 12 May 2021

Patient-specific planning for thermal magnetic resonance of glioblastoma multiforme.
Oberacker, E. ORCID logoORCID: https://orcid.org/0000-0001-7678-6677, Diesch, C., Nadobny, J., Kuehne, A. ORCID logoORCID: https://orcid.org/0000-0002-4133-5056, Wust, P., Ghadjar, P. and Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527
Cancers 13 (8): 1867. 2 April 2021

ECG scoring for the evaluation of therapy-naïve cancer patients to predict cardiotoxicity.
Pohl, J. ORCID logoORCID: https://orcid.org/0000-0001-9142-4869, Mincu, R.I., Mrotzek, S.M., Wakili, R., Mahabadi, A.A. ORCID logoORCID: https://orcid.org/0000-0003-2336-7991, Potthoff, S.K., Siveke, J.T. ORCID logoORCID: https://orcid.org/0000-0002-8772-4778, Keller, U. ORCID logoORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., Rassaf, T. ORCID logoORCID: https://orcid.org/0000-0001-8001-0265, Anker, M.S. and Totzeck, M.
Cancers 13 (6): 1197. 10 March 2021

CD28 co-stimulus achieves superior CAR T cell effector function against solid tumors than 4-1BB co-stimulus.
Textor, A., Grunewald, L., Anders, K. ORCID logoORCID: https://orcid.org/0000-0002-0429-200X, Klaus, A., Schwiebert, S., Winkler, A., Stecklum, M., Rolff, J., Henssen, A.G. ORCID logoORCID: https://orcid.org/0000-0003-1534-778X, Höpken, U.E. ORCID logoORCID: https://orcid.org/0000-0002-0776-4893, Eggert, A., Schulte, J.H. ORCID logoORCID: https://orcid.org/0000-0003-0671-1201, Jensen, M.C., Blankenstein, T. ORCID logoORCID: https://orcid.org/0000-0002-3357-4321 and Künkele, A. ORCID logoORCID: https://orcid.org/0000-0002-8406-5412
Cancers 13 (5): 1050. 2 March 2021

Multi-channel RF supervision module for thermal magnetic resonance based cancer therapy.
Han, H. ORCID logoORCID: https://orcid.org/0000-0003-1205-2900, Oberacker, E. ORCID logoORCID: https://orcid.org/0000-0001-7678-6677, Kuehne, A. ORCID logoORCID: https://orcid.org/0000-0002-4133-5056, Wang, S., Eigentler, T.W. ORCID logoORCID: https://orcid.org/0000-0001-8252-450X, Grass, E. and Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527
Cancers 13 (5): 1001. 28 February 2021

Systematic identification of MACC1-driven metabolic networks in colorectal cancer.
Lisec, J. ORCID logoORCID: https://orcid.org/0000-0003-1220-2286, Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231, Mokrizkij, M., Grötzinger, C. ORCID logoORCID: https://orcid.org/0000-0001-9872-3087, Jaeger, C., Baum, K. ORCID logoORCID: https://orcid.org/0000-0001-7256-0566, Simon, M. ORCID logoORCID: https://orcid.org/0000-0001-7213-9499, Wolf, J. ORCID logoORCID: https://orcid.org/0000-0003-3254-5868, Beindorff, N., Brenner, W. ORCID logoORCID: https://orcid.org/0000-0003-2478-6004 and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 13 (5): 978. 26 February 2021

The relevance of the SH2 domain for c-Src functionality in triple-negative breast cancer cells.
Mayoral-Varo, V. ORCID logoORCID: https://orcid.org/0000-0001-6972-2368, Sánchez-Bailón, M.P. ORCID logoORCID: https://orcid.org/0000-0001-6929-2273, Calcabrini, A. ORCID logoORCID: https://orcid.org/0000-0002-9600-1117, García-Hernández, M., Frezza, V., Martín, M.E. ORCID logoORCID: https://orcid.org/0000-0003-2131-874X, González, V.M. ORCID logoORCID: https://orcid.org/0000-0001-7538-0552 and Martín-Pérez, J. ORCID logoORCID: https://orcid.org/0000-0002-2292-0057
Cancers 13 (3): 462. 26 January 2021

Cold-shock domains - abundance, structure, properties, and nucleic-acid binding.
Heinemann, U. ORCID logoORCID: https://orcid.org/0000-0002-8191-3850 and Roske, Y. ORCID logoORCID: https://orcid.org/0000-0001-6237-388X
Cancers 13 (2): 190. 7 January 2021

Gene expression signatures of a preclinical mouse model during colorectal cancer progression under low-dose metronomic chemotherapy.
Ho-Xuan, H. ORCID logoORCID: https://orcid.org/0000-0003-2911-1559, Lehmann, G., Glazar, P. ORCID logoORCID: https://orcid.org/0000-0003-0842-0088, Gypas, F., Eichner, N., Heizler, K., Schlitt, H.J. ORCID logoORCID: https://orcid.org/0000-0002-3874-0296, Zavolan, M., Rajewsky, N. ORCID logoORCID: https://orcid.org/0000-0002-4785-4332, Meister, G. ORCID logoORCID: https://orcid.org/0000-0002-2098-9923 and Hackl, C.
Cancers 13 (1): 49. 2021

2020

Ubiquitination and ubiquitin-like modifications in multiple myeloma: biology and therapy.
Wirth, M. ORCID logoORCID: https://orcid.org/0000-0002-8340-0872, Schick, M. ORCID logoORCID: https://orcid.org/0009-0003-8626-0611, Keller, U. ORCID logoORCID: https://orcid.org/0000-0002-8485-1958 and Krönke, J.
Cancers 12 (12): 3764. 14 December 2020

Design, implementation, evaluation and application of a 32-channel radio frequency signal generator for thermal magnetic resonance based anti-cancer treatment.
Han, H. ORCID logoORCID: https://orcid.org/0000-0003-1205-2900, Eigentler, T.W. ORCID logoORCID: https://orcid.org/0000-0001-8252-450X, Wang, S., Kretov, E. ORCID logoORCID: https://orcid.org/0000-0001-7480-1466, Winter, L. ORCID logoORCID: https://orcid.org/0000-0002-4381-275X, Hoffmann, W., Grass, E. ORCID logoORCID: https://orcid.org/0000-0002-9718-4170 and Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527
Cancers 12 (7): 1720. 28 June 2020

Small ones to fight a big problem-intervention of cancer metastasis by small molecules.
Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283, Dumbani, M., Güllü, N., Kortüm, B. ORCID logoORCID: https://orcid.org/0000-0003-3734-6665, Vílchez, M.E.A. ORCID logoORCID: https://orcid.org/0000-0002-6249-6932, Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X and Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231
Cancers 12 (6): 1454. 3 June 2020

Progression-dependent altered metabolism in osteosarcoma resulting in different nutrient source dependencies.
Fritsche-Guenther, R. ORCID logoORCID: https://orcid.org/0000-0002-6965-0226, Gloaguen, Y. ORCID logoORCID: https://orcid.org/0000-0003-0493-8592, Kirchner, M. ORCID logoORCID: https://orcid.org/0000-0002-7049-534X, Mertins, P. ORCID logoORCID: https://orcid.org/0000-0002-2245-528X, Tunn, P.U. and Kirwan, J.A. ORCID logoORCID: https://orcid.org/0000-0002-5423-1651
Cancers 12 (6): 1371. 27 May 2020

Controlled release of therapeutics from thermoresponsive nanogels: a thermal magnetic resonance feasibility study.
Ji, Y. ORCID logoORCID: https://orcid.org/0000-0002-8721-5025, Winter, L. ORCID logoORCID: https://orcid.org/0000-0002-4381-275X, Navarro, L., Ku, M.C. ORCID logoORCID: https://orcid.org/0000-0003-0963-2461, Periquito, J.S. ORCID logoORCID: https://orcid.org/0000-0003-3702-9264, Pham, M., Hoffmann, W., Theune, L.E., Calderón, M. and Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527
Cancers 12 (6): 1380. 27 May 2020

Solving the time- and frequency-multiplexed problem of constrained radiofrequency induced hyperthermia.
Kuehne, A. ORCID logoORCID: https://orcid.org/0000-0002-4133-5056, Oberacker, E. ORCID logoORCID: https://orcid.org/0000-0001-7678-6677, Waiczies, H. ORCID logoORCID: https://orcid.org/0000-0001-6651-4790 and Niendorf, T. ORCID logoORCID: https://orcid.org/0000-0001-7584-6527
Cancers 12 (5): 1072. May 2020

Functional classification of TP53 mutations in acute myeloid leukemia.
Dutta, S., Pregartner, G., Rücker, F.G., Heitzer, E. ORCID logoORCID: https://orcid.org/0000-0002-8815-7859, Zebisch, A. ORCID logoORCID: https://orcid.org/0000-0002-4861-7021, Bullinger, L. ORCID logoORCID: https://orcid.org/0000-0002-5890-5510, Berghold, A., Döhner, K. and Sill, H. ORCID logoORCID: https://orcid.org/0000-0003-0993-4371
Cancers 12 (3): 637. 10 March 2020

High specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG positive Ewing sarcoma.
Orth, M.F. ORCID logoORCID: https://orcid.org/0000-0002-1789-6427, Hölting, T.L.B., Dallmayer, M., Wehweck, F.S., Paul, T., Musa, J. ORCID logoORCID: https://orcid.org/0000-0002-9138-1819, Baldauf, M.C., Surdez, D. ORCID logoORCID: https://orcid.org/0000-0002-7118-7859, Delattre, O., Knott, M.M.L. ORCID logoORCID: https://orcid.org/0000-0002-6995-3702, Romero-Pérez, L. ORCID logoORCID: https://orcid.org/0000-0003-3196-4382, Kasan, M. ORCID logoORCID: https://orcid.org/0000-0002-9031-2109, Cidre-Aranaz, F. ORCID logoORCID: https://orcid.org/0000-0002-0246-7179, Gerke, J.S., Ohmura, S. ORCID logoORCID: https://orcid.org/0000-0002-0930-5172, Li, J., Marchetto, A., Henssen, A.G. ORCID logoORCID: https://orcid.org/0000-0003-1534-778X, Özen, Ö., Sugita, S., Hasegawa, T., Kanaseki, T., Bertram, S., Dirksen, U. ORCID logoORCID: https://orcid.org/0000-0002-5435-7860, Hartmann, W., Kirchner, T. and Grünewald, T.G.P. ORCID logoORCID: https://orcid.org/0000-0003-0920-7377
Cancers 12 (3): 644. 10 March 2020

Efficacy of crizotinib, ceritinib, and alectinib in ALK-positive non-small cell lung cancer treatment: a meta-analysis of clinical trials.
Hoang, T., Myung, S.K., Pham, T.T. ORCID logoORCID: https://orcid.org/0000-0002-2129-0911 and Park, B.
Cancers 12 (3): 526. 25 February 2020

2019

Hypertonicity-affected genes are differentially expressed in clear cell renal cell carcinoma and correlate with cancer-specific survival.
Kandabarau, S., Leiz, J. ORCID logoORCID: https://orcid.org/0000-0002-6531-7047, Krohn, K., Winter, S., Bedke, J., Schwab, M., Schaeffeler, E. and Edemir, B.
Cancers 12 (1): 6. 18 December 2019

A novel predictor tool of biochemical recurrence after radical prostatectomy based on a five-microRNA tissue signature.
Zhao, Z., Weickmann, S., Jung, M., Lein, M., Kilic, E., Stephan, C., Erbersdobler, A., Fendler, A. ORCID logoORCID: https://orcid.org/0000-0002-7267-0981 and Jung, K.
Cancers 11 (10): 1603. 21 October 2019

Circular RNAs in clear cell renal cell carcinoma: their microarray-based identification, analytical validation, and potential use in a clinico-genomic model to improve prognostic accuracy.
Franz, A., Ralla, B., Weickmann, S., Jung, M., Rochow, H., Stephan, C., Erbersdobler, A., Kilic, E., Fendler, A. ORCID logoORCID: https://orcid.org/0000-0002-7267-0981 and Jung, K.
Cancers 11 (10): 1473. 30 September 2019

Circulating MACC1 transcripts in glioblastoma patients predict prognosis and treatment response.
Hagemann, C., Neuhaus, N., Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283, Kessler, A.F., Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Herrmann, P., Eyrich, M. ORCID logoORCID: https://orcid.org/0000-0002-8099-5903, Freitag, B., Linsenmann, T., Monoranu, C.M., Ernestus, R.I., Löhr, M. and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 11 (6): 825. 13 June 2019

2018

miR-9-5p in nephrectomy specimens is a potential predictor of primary resistance to first-line treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Ralla, B., Busch, J., Flörcken, A. ORCID logoORCID: https://orcid.org/0000-0001-6462-7214, Westermann, J., Zhao, Z., Kilic, E., Weickmann, S., Jung, M., Fendler, A. ORCID logoORCID: https://orcid.org/0000-0002-7267-0981 and Jung, K.
Cancers 10 (9): 321. 10 September 2018

2016

S100A4 in cancer metastasis: Wnt signaling-driven interventions for metastasis restriction.
Dahlmann, M. ORCID logoORCID: https://orcid.org/0000-0002-0036-5283, Kobelt, D. ORCID logoORCID: https://orcid.org/0000-0002-9373-0648, Walther, W. ORCID logoORCID: https://orcid.org/0000-0003-2884-0231, Mudduluru, G. and Stein, U. ORCID logoORCID: https://orcid.org/0000-0001-7006-282X
Cancers 8 (6): 59. 20 June 2016

This list was generated on Thu Jun 18 12:51:57 2026 UTC.
Open Access
MDC Library